These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34875719)

  • 1. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
    Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
    J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical distributional defects in mutant genes associated with dominant intermediate Charcot-Marie-Tooth disease type C in an adenovirus-mediated mouse model.
    Lee S; Panthi S; Jo HW; Cho J; Kim MS; Jeong NY; Song IO; Jung J; Huh Y
    Neural Regen Res; 2017 Mar; 12(3):486-492. PubMed ID: 28469666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
    McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
    Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
    Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
    Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
    Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
    Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Model of Hereditary Sensory and Autonomic Neuropathy Type 1 Reveals a Role of Glycosphingolipids in Neuronal Polarity.
    Cui M; Ying R; Jiang X; Li G; Zhang X; Zheng J; Tam KY; Liang B; Shi A; Göbel V; Zhang H
    J Neurosci; 2019 Jul; 39(29):5816-5834. PubMed ID: 31138658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
    Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
    J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I).
    Houlden H; King R; Blake J; Groves M; Love S; Woodward C; Hammans S; Nicoll J; Lennox G; O'Donovan DG; Gabriel C; Thomas PK; Reilly MM
    Brain; 2006 Feb; 129(Pt 2):411-25. PubMed ID: 16364956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy.
    Rhymes ER; Simkin RL; Qu J; Villarroel-Campos D; Surana S; Tong Y; Shapiro R; Burgess RW; Yang XL; Schiavo G; Sleigh JN
    Neurobiol Dis; 2024 Jun; 195():106501. PubMed ID: 38583640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
    Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
    J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary sensory neuropathies.
    Houlden H; Blake J; Reilly MM
    Curr Opin Neurol; 2004 Oct; 17(5):569-77. PubMed ID: 15367861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and Molecular Characterization of New
    Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
    Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
    N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
    Hornemann T; Penno A; Richard S; Nicholson G; van Dijk FS; Rotthier A; Timmerman V; von Eckardstein A
    Neurogenetics; 2009 Apr; 10(2):135-43. PubMed ID: 19132419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy.
    Suriyanarayanan S; Auranen M; Toppila J; Paetau A; Shcherbii M; Palin E; Wei Y; Lohioja T; Schlotter-Weigel B; Schön U; Abicht A; Rautenstrauss B; Tyynismaa H; Walter MC; Hornemann T; Ylikallio E
    Neuromolecular Med; 2016 Mar; 18(1):81-90. PubMed ID: 26573920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy.
    Storkebaum E; Leitão-Gonçalves R; Godenschwege T; Nangle L; Mejia M; Bosmans I; Ooms T; Jacobs A; Van Dijck P; Yang XL; Schimmel P; Norga K; Timmerman V; Callaerts P; Jordanova A
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11782-7. PubMed ID: 19561293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.